D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 111 Citations 41,089 686 World Ranking 3119 National Ranking 1782

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Major depressive disorder

His primary areas of investigation include Anesthesia, Psychiatry, Addiction, Substance abuse and Methadone. Thomas R. Kosten has included themes like Cocaine dependence, Randomized controlled trial, Buprenorphine, Placebo and Abstinence in his Anesthesia study. His Psychiatry study integrates concerns from other disciplines, such as Treatment outcome and Clinical psychology.

His studies in Addiction integrate themes in fields like Bioinformatics, Anxiety, Tiagabine, Opiate and Depression. His work deals with themes such as Vulnerability, Methamphetamine, Psychometrics and Drug, which intersect with Substance abuse. His Methadone research includes elements of Internal medicine, Urine and Opioid.

His most cited work include:

  • Substance Use Disorders in Patients With Posttraumatic Stress Disorder: A Review of the Literature (749 citations)
  • Neurobiological similarities in depression and drug dependence : A self-medication hypothesis (628 citations)
  • Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. (613 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Psychiatry, Internal medicine, Anesthesia, Addiction and Methadone. His research links Clinical psychology with Psychiatry. Thomas R. Kosten has researched Internal medicine in several fields, including Endocrinology, Oncology, Genotype and Schizophrenia.

His research integrates issues of Clinical trial, Cocaine dependence, Randomized controlled trial, Placebo and Abstinence in his study of Anesthesia. As part of the same scientific family, he usually focuses on Placebo, concentrating on Pharmacology and intersecting with Pharmacogenetics. His Methadone research is multidisciplinary, incorporating elements of Buprenorphine and Desipramine.

He most often published in these fields:

  • Psychiatry (37.19%)
  • Internal medicine (28.65%)
  • Anesthesia (23.52%)

What were the highlights of his more recent work (between 2013-2021)?

  • Psychiatry (37.19%)
  • Internal medicine (28.65%)
  • Placebo (16.03%)

In recent papers he was focusing on the following fields of study:

Thomas R. Kosten mainly focuses on Psychiatry, Internal medicine, Placebo, Addiction and Opioid use disorder. His work carried out in the field of Psychiatry brings together such families of science as Cannabinoid, MEDLINE and Clinical psychology. His Internal medicine research incorporates themes from Endocrinology, Oncology, Genotype and Positive and Negative Syndrome Scale.

His Placebo study combines topics in areas such as Anesthesia, Agonist, Randomized controlled trial, Cocaine dependence and Abstinence. Thomas R. Kosten focuses mostly in the field of Addiction, narrowing it down to topics relating to Substance abuse and, in certain cases, Drug. His work in Opioid use disorder covers topics such as Buprenorphine which are related to areas like Methadone, Medical prescription, Naloxone and Pharmacotherapy.

Between 2013 and 2021, his most popular works were:

  • Vaccine for cocaine dependence: A randomized double-blind placebo-controlled efficacy trial (72 citations)
  • Brief Report: Increased Addictive Internet and Substance Use Behavior During the COVID-19 Pandemic in China. (66 citations)
  • Vaccines against stimulants: cocaine and MA (42 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Major depressive disorder

His main research concerns Psychiatry, Schizophrenia, Positive and Negative Syndrome Scale, Internal medicine and Addiction. In general Psychiatry study, his work on Methadone often relates to the realm of Knowledge infrastructure, thereby connecting several areas of interest. His Schizophrenia research incorporates themes from Clinical psychology and Adjunctive treatment.

His work carried out in the field of Positive and Negative Syndrome Scale brings together such families of science as Genetics, Lipid profile, Protective factor, Psychopathology and Repeatable Battery for the Assessment of Neuropsychological Status. His Internal medicine research focuses on subjects like Endocrinology, which are linked to Gene polymorphism, Genotype and Brain-derived neurotrophic factor. The various areas that Thomas R. Kosten examines in his Addiction study include Coping behavior, Immunology, Intensive care medicine, Substance use and Pandemic.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Substance Use Disorders in Patients With Posttraumatic Stress Disorder: A Review of the Literature

Leslie K. Jacobsen;Steven M. Southwick;Thomas R. Kosten.
American Journal of Psychiatry (2001)

1277 Citations

Neurobiological similarities in depression and drug dependence : A self-medication hypothesis

Athina Markou;Thomas R. Kosten;George F. Koob.
Neuropsychopharmacology (1998)

966 Citations

Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.

Bridget A. Martell;Patrick G. O'Connor;Robert D. Kerns;William C. Becker.
Annals of Internal Medicine (2007)

928 Citations

Management of drug and alcohol withdrawal.

Thomas R. Kosten;Patrick G. O'Connor.
The New England Journal of Medicine (2003)

659 Citations

Urinary free-cortisol levels in posttraumatic stress disorder patients.

John W. Mason;Earl L. Giller;Thomas R. Kosten;Robert B. Ostroff.
Journal of Nervous and Mental Disease (1986)

627 Citations

The Neurobiology of Opioid Dependence: Implications for Treatment

Thomas R Kosten;Tony P George.
Science & Practice Perspectives (2002)

550 Citations

Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study.

Bruce J. Rounsaville;Thomas R. Kosten;Myrna M. Weissman;Herbert D. Kleber.
Archives of General Psychiatry (1986)

526 Citations

Desipramine facilitation of initial cocaine abstinence.

Frank H. Gawin;Herbert D. Kleber;Robert Byck;Bruce J. Rounsaville.
Archives of General Psychiatry (1989)

497 Citations

Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder

Thomas R. Kosten;John W. Mason;Earl L. Giller;Robert B. Ostroff.
Psychoneuroendocrinology (1987)

461 Citations

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

Tony P. George;Douglas M. Ziedonis;Alan Feingold;W. Thomas Pepper.
American Journal of Psychiatry (2000)

448 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas R. Kosten

Xiang Yang Zhang

Xiang Yang Zhang

Chinese Academy of Sciences

Publications: 135

Kathleen T. Brady

Kathleen T. Brady

Medical University of South Carolina

Publications: 104

Tony P. George

Tony P. George

Centre for Addiction and Mental Health

Publications: 95

Rachel Yehuda

Rachel Yehuda

Icahn School of Medicine at Mount Sinai

Publications: 90

Kathleen M. Carroll

Kathleen M. Carroll

Yale University

Publications: 89

Edward V. Nunes

Edward V. Nunes

Columbia University

Publications: 84

Nora D. Volkow

Nora D. Volkow

National Institutes of Health

Publications: 82

Rajita Sinha

Rajita Sinha

Yale University

Publications: 72

Bruce J. Rounsaville

Bruce J. Rounsaville

Yale University

Publications: 69

Marc N. Potenza

Marc N. Potenza

Yale University

Publications: 64

Maxine L. Stitzer

Maxine L. Stitzer

Johns Hopkins University School of Medicine

Publications: 64

Frances R. Levin

Frances R. Levin

Columbia University

Publications: 64

Henry R. Kranzler

Henry R. Kranzler

University of Pennsylvania

Publications: 63

Nancy M. Petry

Nancy M. Petry

University of Connecticut

Publications: 61

Kim D. Janda

Kim D. Janda

Scripps Research Institute

Publications: 61

Craig R. Rush

Craig R. Rush

University of Kentucky

Publications: 61

Trending Scientists

Sergey Zelik

Sergey Zelik

University of Surrey

Peter E. Hart

Peter E. Hart

Independent Scientist / Consultant, US

David L. Ashley

David L. Ashley

Georgia State University

Daniel L. DuBois

Daniel L. DuBois

Pacific Northwest National Laboratory

Antonio Miotello

Antonio Miotello

University of Trento

Garry R. Cutting

Garry R. Cutting

Johns Hopkins University School of Medicine

Karin Musier-Forsyth

Karin Musier-Forsyth

The Ohio State University

John L. Wang

John L. Wang

Michigan State University

Francisco Solano

Francisco Solano

University of Murcia

Cornelis A. M. de Haan

Cornelis A. M. de Haan

Utrecht University

Graham Yielding

Graham Yielding

Badley Geoscience Ltd

Jürgen Vogt

Jürgen Vogt

European Commission

Antonio Egidio Nardi

Antonio Egidio Nardi

Federal University of Rio de Janeiro

Arthur D. Anastopoulos

Arthur D. Anastopoulos

University of North Carolina at Greensboro

Yair Lotan

Yair Lotan

The University of Texas Southwestern Medical Center

Ka Ho Mok

Ka Ho Mok

Lingnan University

Something went wrong. Please try again later.